SCHEMBL19869006

SCHEMBL19869006

CC(C)Cc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccsc3)[nH]2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK11 Q15759 14/20 0.52
MAPK14 Q16539 14/20 0.52
MAPK13 O15264 13/20 0.52
GCGR P47871 13/20 0.52
MAPK12 P53778 13/20 0.52
ALOX5 P09917 13/20 0.52
CSNK1A1 P48729 5/20 0.51
CSNK1D P48730 5/20 0.51
PRKD3 O94806 4/20 0.51
MAP4K4 O95819 4/20 0.51
FRK P42685 4/20 0.51
MAPK9 P45984 4/20 0.51
GSK3B P49841 4/20 0.51
CLK4 Q9HAZ1 3/20 0.51
PRKD2 Q9BZL6 3/20 0.51
PTK6 Q13882 3/20 0.51
PRKACA P17612 3/20 0.46
SLK Q9H2G2 3/20 0.46
LCK P06239 2/20 0.46
ERBB4 Q15303 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19857273 0.85 MAPK11 (0.73) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL19869013 0.81 MAPK11 (0.54) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL19868986 0.81 MAPK14 (0.70) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL19868983 0.79 ALOX5 (0.51) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL19869010 0.79 MAPK13 (0.55) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL19869008 0.79 ALOX5 (0.68) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL19869009 0.78 ALOX5 (0.50) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL7228108 0.77 MAPK14 (0.76) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL13115516 0.77 MAPK11 (0.47) MAPK11MAPK14MAPK13GCGRMAPK12
SCHEMBL19869007 0.76 ALOX5 (0.72) MAPK11MAPK14MAPK13GCGRMAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS CREB1, PPP6R1, PPP1R10 MAPK11 903/4885MAPK14 440/4885MAPK13 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.